Biomarin Pharmaceutical Inc R&D Day Transcript
Okay. Good morning, everybody. For those on the webcast, good morning, afternoon or evening, depending on where you are. It's a great pleasure to be here. As you might remember, we did our last R&D Day a couple of years ago. And it was webcast because we've seen the tails of COVID, I guess. But now we can all get together in person.
So basically, we are -- when we last met, we were in the middle of putting our strategy together for the long-term performance of the company. But now, I would say, BioMarin into -- is starting into a financial growth story, whereby we have the luxury of being able to grow the profitability of the company as we've had in the past few quarters, while continuing to invest in research and development to ensure a successful future of BioMarin beyond the end of the decade here, after VOXZOGO and ROCTAVIAN will start turning into more mature products. So it's a great pleasure to be here again.
We've been -- I think we've been successful in the past by staying true to our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
